The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death

covid-trials

Covid Trials, News on Covid Trials, stories on Covid Trials, articles on Covid Trials, Covid Trials stories at Wion, Covid Trials news, Covid Trials latest news

covid trials

WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death